Pfizer beats Q4 profit estimates on strong drug demand
Robust demand for its heart and oncology drugs helped achieve total sales for the quarter of US$17.56 billion Pfizer on Tuesday (Feb 3)…
Tag
Robust demand for its heart and oncology drugs helped achieve total sales for the quarter of US$17.56 billion Pfizer on Tuesday (Feb 3)…
Pfizer has rolled out a sweeping cost reduction programme in response to the drop in Covid-19 sales Pfizer on Tuesday (Dec 16) forecast…
Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the pandemic’s most lucrative…
Pfizer raised its 2025 profit forecast for the second time this year, as ongoing cost cuts helped make up for slow sales growth that’s…
The COVID-19 vaccine by Pfizer may lead to vision loss and increase the risk of eye damage, according to a new study. The shocking…
Pfizer increased the number of shares to 640 million from 540 million after the sale began Pfizer has raised about US$3.2 billion from the…